Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

BACKGROUND: Thioguanine (TG) is a thiopurine which has been used for patients with inflammatory bowel disease (IBD), who have failed azathioprine (AZA) or mercaptopurine (MP) due to adverse events or suboptimal response. Its widespread use has been hampered due to concerns about nodular regenerative...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayoumy, Ahmed B., van Liere, Elsa L. S. A., Simsek, Melek, Warner, Ben, Loganayagam, Aathavan, Sanderson, Jeremy D., Anderson, Simon, Nolan, Jonathan, de Boer, Nanne K., Mulder, Chris J. J., Ansari, Azhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488521/
https://www.ncbi.nlm.nih.gov/pubmed/32917155
http://dx.doi.org/10.1186/s12876-020-01441-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488521/
https://www.ncbi.nlm.nih.gov/pubmed/32917155
http://dx.doi.org/10.1186/s12876-020-01441-6

Ejemplares similares